BioSequence Overview
- Year Founded
-
2012
- Status
-
Acquired/Merged
- Employees
-
3
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
BioSequence General Information
Description
Manufacturer of precision medicine for the treatment of cancer and other genetic diseases. The company offers genomic biomarker tests designed to detect the molecular alterations of a specific tumor, predict resistance to treatments and identify the most effective therapeutic options as well offers molecular profiling, data interpretation services and clinical decision online tools, thereby enabling healthcare professionals to monitor patient's response to therapy in real-time.
Contact Information
Website
www.bio-sequence.com(Operating Subsidiary)
Corporate Office
- Avenida Amado Granell Mesado nº75
- Office 8B 46013
- 46013 Valencia
- Spain
Corporate Office
- Avenida Amado Granell Mesado nº75
- Office 8B 46013
- 46013 Valencia
- Spain
BioSequence Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BioSequence Signals
BioSequence FAQs
-
When was BioSequence founded?
BioSequence was founded in 2012.
-
Where is BioSequence headquartered?
BioSequence is headquartered in Valencia, Spain.
-
What is the size of BioSequence?
BioSequence has 3 total employees.
-
What industry is BioSequence in?
BioSequence’s primary industry is Drug Discovery.
-
Is BioSequence a private or public company?
BioSequence is a Private company.
-
What is BioSequence’s current revenue?
The current revenue for BioSequence is .
-
When was BioSequence acquired?
BioSequence was acquired on 23-Feb-2017.
-
Who acquired BioSequence?
BioSequence was acquired by OncoDNA.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process